Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.

Evangelos Dimakakos; Georgia Gomatou; Mariella Catalano; Dan-Mircea Olinic; Alex C Spyropoulos; Anna Falanga; Anthony Maraveyas; Aaron Liew; Sam Schulman; Jill Belch; Grigorios Gerotziafas; Peter Marschang; Benilde Cosmi; Jonas Spaak; Konstantinos Syrigos

doi:10.21873/anticanres.15815

Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.

Evangelos Dimakakos
, Georgia Gomatou
, Mariella Catalano
, Dan-Mircea Olinic
, Alex C Spyropoulos
, Anna Falanga
, Anthony Maraveyas
, Aaron Liew
, Sam Schulman
, Jill Belch
, Grigorios Gerotziafas
, Peter Marschang
, Benilde Cosmi
, Jonas Spaak
, Konstantinos Syrigos

Krankenhaus Bozen

Research output: Contribution to journal › Review article › peer-review

6 Citations (Web of Science)

Original language	English
Pages (from-to)	3261-3274
Journal	ANTICANCER RESEARCH
Volume	42
Issue number	7
DOIs	https://doi.org/10.21873/anticanres.15815
Publication status	Published - 2022

Keywords

VENOUS THROMBOEMBOLISM
AMBULATORY PATIENTS
ARTERIAL THROMBOSIS
TISSUE FACTOR
RIVAROXABAN
PREDICTION
EVENTS
HOSPITALIZATION
EPIDEMIOLOGY
CHEMOTHERAPY

Access to Document

10.21873/anticanres.15815

Cite this

Dimakakos, E., Gomatou, G., Catalano, M., Olinic, D.-M., Spyropoulos, A. C., Falanga, A., Maraveyas, A., Liew, A., Schulman, S., Belch, J., Gerotziafas, G., Marschang, P., Cosmi, B., Spaak, J., & Syrigos, K. (2022). Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art. ANTICANCER RESEARCH , 42(7), 3261-3274. https://doi.org/10.21873/anticanres.15815

Dimakakos, Evangelos ; Gomatou, Georgia ; Catalano, Mariella et al. / Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art. In: ANTICANCER RESEARCH 2022 ; Vol. 42, No. 7. pp. 3261-3274.

@article{f3c0a62748524c86b43b3f6f6eed02c1,

title = "Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.",

keywords = "VENOUS THROMBOEMBOLISM, AMBULATORY PATIENTS, ARTERIAL THROMBOSIS, TISSUE FACTOR, RIVAROXABAN, PREDICTION, EVENTS, HOSPITALIZATION, EPIDEMIOLOGY, CHEMOTHERAPY",

author = "Evangelos Dimakakos and Georgia Gomatou and Mariella Catalano and Dan-Mircea Olinic and Spyropoulos, \{Alex C\} and Anna Falanga and Anthony Maraveyas and Aaron Liew and Sam Schulman and Jill Belch and Grigorios Gerotziafas and Peter Marschang and Benilde Cosmi and Jonas Spaak and Konstantinos Syrigos",

note = "Lehr-KH Bozen: Marschang: Department of Internal Medicine, Central Hospital of Bolzano (SABES-ASDAA), Bolzano, Italy",

year = "2022",

doi = "10.21873/anticanres.15815",

language = "English",

volume = "42",

pages = "3261--3274",

journal = "ANTICANCER RESEARCH ",

issn = "0250-7005",

number = "7",

}

Dimakakos, E, Gomatou, G, Catalano, M, Olinic, D-M, Spyropoulos, AC, Falanga, A, Maraveyas, A, Liew, A, Schulman, S, Belch, J, Gerotziafas, G, Marschang, P, Cosmi, B, Spaak, J & Syrigos, K 2022, 'Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.', ANTICANCER RESEARCH , vol. 42, no. 7, pp. 3261-3274. https://doi.org/10.21873/anticanres.15815

Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art. / Dimakakos, Evangelos; Gomatou, Georgia; Catalano, Mariella et al.
In: ANTICANCER RESEARCH , Vol. 42, No. 7, 2022, p. 3261-3274.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.

AU - Dimakakos, Evangelos

AU - Gomatou, Georgia

AU - Catalano, Mariella

AU - Olinic, Dan-Mircea

AU - Spyropoulos, Alex C

AU - Falanga, Anna

AU - Maraveyas, Anthony

AU - Liew, Aaron

AU - Schulman, Sam

AU - Belch, Jill

AU - Gerotziafas, Grigorios

AU - Marschang, Peter

AU - Cosmi, Benilde

AU - Spaak, Jonas

AU - Syrigos, Konstantinos

N1 - Lehr-KH Bozen: Marschang: Department of Internal Medicine, Central Hospital of Bolzano (SABES-ASDAA), Bolzano, Italy

PY - 2022

Y1 - 2022

KW - VENOUS THROMBOEMBOLISM

KW - AMBULATORY PATIENTS

KW - ARTERIAL THROMBOSIS

KW - TISSUE FACTOR

KW - RIVAROXABAN

KW - PREDICTION

KW - EVENTS

KW - HOSPITALIZATION

KW - EPIDEMIOLOGY

KW - CHEMOTHERAPY

U2 - 10.21873/anticanres.15815

DO - 10.21873/anticanres.15815

M3 - Review article

C2 - 35790272

SN - 0250-7005

VL - 42

SP - 3261

EP - 3274

JO - ANTICANCER RESEARCH

JF - ANTICANCER RESEARCH

IS - 7

ER -

Dimakakos E, Gomatou G, Catalano M, Olinic DM, Spyropoulos AC, Falanga A et al. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art. ANTICANCER RESEARCH . 2022;42(7):3261-3274. doi: 10.21873/anticanres.15815